1. Home
  2. GKOS vs GBCI Comparison

GKOS vs GBCI Comparison

Compare GKOS & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.41

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

HOLD

Current Price

$47.24

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
GBCI
Founded
1998
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.9B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
GBCI
Price
$113.41
$47.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
5
Target Price
$127.71
$53.60
AVG Volume (30 Days)
641.9K
861.5K
Earning Date
02-19-2026
01-22-2026
Dividend Yield
N/A
2.78%
EPS Growth
N/A
26.70
EPS
N/A
2.05
Revenue
$469,820,000.00
$900,148,000.00
Revenue This Year
$31.15
$13.47
Revenue Next Year
$24.15
$27.72
P/E Ratio
N/A
$23.15
Revenue Growth
30.38
15.35
52 Week Low
$73.16
$36.76
52 Week High
$163.71
$52.81

Technical Indicators

Market Signals
Indicator
GKOS
GBCI
Relative Strength Index (RSI) 58.14 66.20
Support Level $109.07 $46.16
Resistance Level $115.00 $48.15
Average True Range (ATR) 2.76 1.14
MACD -0.95 0.20
Stochastic Oscillator 44.01 87.62

Price Performance

Historical Comparison
GKOS
GBCI

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

Share on Social Networks: